ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Global Synthetic Biology market Research Report Released with growth, latest trends & forecasts till 2022 – Cryptoinist (press release)

Global Synthetic Biology market Research Report Released with growth, latest trends & forecasts till 2022Cryptoinist (press release)Here comes the Global Synthetic Biology Market. This is an eminent report providing details and insights on Global … Continue reading

2018-06-02 Michael Zand NEWS

‘Trojan horse’ artificial enzyme smuggles unnatural reactions into cells – Chemistry World

Continue reading

2018-06-02 Michael Zand NEWS

Reading Roundup: Robots, Hiring Time, CRISPR Wars, More – CALIFORNIA

‘Trojan horse’ artificial enzyme smuggles unnatural reactions into cells
Chemistry World
One of the tools scientists use to expand the scope of enzymes is synthetic biology, relying on combining pre-existing cellular components. But just as you are limited in what you can build using a set of Lego blocks, synthetic biology is similarly …

Continue reading

2018-06-02 Michael Zand NEWS

Blood stem cell editing enables myeloid cell targeting with CAR T – BioWorld Online

Blood stem cell editing enables myeloid cell targeting with CAR TBioWorld OnlineBlood stem cell editing enables myeloid cell targeting with CAR T. By Anette Breindl Senior Science Editor. Friday, June 1, 2018. In the quest to bring chimeric antigen rec… Continue reading

2018-06-02 Michael Zand NEWS

The FDA Has Just Put The Brakes on a Major CRISPR Trial in Humans – ScienceAlert


Wall Street Journal

Reading Roundup: Robots, Hiring Time, CRISPR Wars, More
CALIFORNIA
CRISPR Wars. UC Berkeley’s Jennifer Doudna has chalked up another award for her discovery of the revolutionary CRISPR-Cas9 gene-editing tool—and a big one at that. The Kavli Prize in nanoscience is worth $1 million and will be shared among the three …
Science Prizes Add Intrigue to the Race for the NobelWall Street Journal

all 6 news articles »

Continue reading

2018-06-02 Michael Zand NEWS

CRISPR: life-changing, world-changing science that will revolutionize medicine – MSR News Online

The FDA Has Just Put The Brakes on a Major CRISPR Trial in Humans
ScienceAlert
You’ve heard it before: CRISPR has the potential to change our lives for the better. But first, we have to give it a chance. In December, gene-editing company CRISPR Therapeutics announced a partnership with biotech company Vertex to develop CTX001, …

Continue reading

2018-06-02 Michael Zand NEWS

Revolutionary Stem Cell Therapy To Fix Broken Human Hearts Approved In Japan – IFLScience


MSR News Online

CRISPR: life-changing, world-changing science that will revolutionize medicine
MSR News Online
Dr. Crutchfield, my nephew said there may be a new treatment called CRISPR for hundreds of diseases. What in the world is CRISPR? CRISPR is science and medicine’s potential secret weapon for treating and preventing inherited diseases like sickle cell …

Continue reading

2018-06-02 Michael Zand NEWS

Bluebird Bio’s Killer T-Cells Have “Impressive” Results Against Myeloma – Forbes


IFLScience

Revolutionary Stem Cell Therapy To Fix Broken Human Hearts Approved In Japan
IFLScience
As reported by Nature News, scientists in Japan now have official permission to treat people with heart disease with stem cells. Led by cardiac surgeons at Osaka University, they’ll be used to regenerate damaged muscle, also a common feature post-heart …

Continue reading

2018-06-01 Michael Zand NEWS
  • 1
  • …
  • 19
  • 20
  • 21
  • 22
  • 23
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

Forbes

Bluebird Bio’s Killer T–Cells Have “Impressive” Results Against Myeloma
Forbes
based Bluebird Bio and Summit, N.J.-based Celgene, is a form of CAR-T, short for chimeric antigen receptor T–cell, for the type of white blood cell and the modifications made to it. This CAR-T targets a protein found in multiple myeloma cells called B …
Cellular Therapies for Multiple Myeloma: A Paradigm ShiftCancer Network
Bluebird Bio CAR–T delays multiple myeloma progression by one year, but is that enough?STAT
#ASCO18: Bluebird & Celgene’s CAR–T nears 1 year of PFS in multiple myelomaFierceBiotech
Business Wire (press release) –Reuters
all 7 news articles »